Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 14/20 | 0.40 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | IDH2 | P48735 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL586480 | 0.96 | TACR1 (0.42) | TACR1MAPTTDP1ENPP2 | |
| SCHEMBL581119 | 0.96 | NOTUM (0.43) | TACR1NOTUMIDH2FFAR2 | |
| SCHEMBL580684 | 0.87 | NOTUM (0.42) | TACR1NOTUMMAPTIDH2FFAR2 | |
| SCHEMBL587743 | 0.87 | MAPT (0.41) | TACR1MAPTTDP1ENPP2 | |
| SCHEMBL580911 | 0.86 | TACR1 (0.40) | TACR1NOTUM | |
| SCHEMBL586941 | 0.86 | NOTUM (0.45) | NOTUMMAPTTDP1IDH2 | |
| SCHEMBL586674 | 0.85 | NOTUM (0.44) | NOTUMMAPTTDP1 | |
| SCHEMBL581040 | 0.85 | TACR1 (0.47) | TACR1NOTUMIDH2 | |
| SCHEMBL582518 | 0.82 | TACR1 (0.42) | TACR1 | |
| SCHEMBL582517 | 0.82 | TACR1 (0.42) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2417131-A1 | ISOXAZOL-3(2H)-ONE ANALOGS AS THERAPEUTIC AGENTS | AstraZeneca AB (SE) | 2012-02-15 | — | — | EP | disclosed |
| WO-2010117323-A1 | METHOD AND APPARATUS FOR PRODUCING HEAT ENERGY AND CARBON DIOXIDE | ASTRAZENECA AB (SE) | 2010-10-14 | — | — | WO | disclosed |